Qiu YH - Search Results

1

Prognostic value of serum high-density lipoprotein cholesterol in patients with gallbladder cancer.

Yuan B, Fu J, Yu WL, Fu XH, Qiu YH, Yin L, Zhu B, Zhang YJ. Yuan B, et al. Among authors: qiu yh. Rev Esp Enferm Dig. 2019 Nov;111(11):839-845. doi: 10.17235/reed.2019.6201/2019. Rev Esp Enferm Dig. 2019. PMID: 31595756 Free article.

2

miR-204 inhibits epithelial to mesenchymal transition by targeting slug in intrahepatic cholangiocarcinoma cells.

Qiu YH, Wei YP, Shen NJ, Wang ZC, Kan T, Yu WL, Yi B, Zhang YJ. Qiu YH, et al. Cell Physiol Biochem. 2013;32(5):1331-41. doi: 10.1159/000354531. Epub 2013 Nov 22. Cell Physiol Biochem. 2013. PMID: 24280681 Free article.

3

Downregulation of A20 increases the cytotoxicity of IFN-γ in hepatocellular carcinoma cells.

Yin L, Fang Z, Shen NJ, Qiu YH, Li AJ, Zhang YJ. Yin L, et al. Among authors: qiu yh. Drug Des Devel Ther. 2017 Sep 26;11:2841-2850. doi: 10.2147/DDDT.S135993. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 29033545 Free PMC article.

4

Residual cancer is a strong predictor of survival in T3 incidental gallbladder cancer.

You C, Xie M, Ling M, Yang F, Qiu Y, Li J. You C, et al. BMC Surg. 2022 Dec 28;22(1):443. doi: 10.1186/s12893-022-01869-5. BMC Surg. 2022. PMID: 36577967 Free PMC article.

5

Hepatic blood inflow occlusion with/without hemihepatic artery control versus the Pringle maneuver in resection of hepatocellular carcinoma: a retrospective comparative analysis.

Yi B, Qiu YH, Liu C, Luo XJ, Jiang XQ, Tan WF, Wu MC. Yi B, et al. Among authors: qiu yh. Chin Med J (Engl). 2010 Jun;123(11):1413-6. Chin Med J (Engl). 2010. PMID: 20819598

6

Sorafenib extends the survival time of patients with multiple recurrences of hepatocellular carcinoma after liver transplantation.

TAN WF, Qiu ZQ, YU Y, RAN RZ, YI B, LAU WY, LIU C, QIU YH, FENG FL, WANG JH, YAN PN, ZHANG BH, WU MC, LUO XJ, JIANG XQ. TAN WF, et al. Among authors: qiu yh, qiu zq. Acta Pharmacol Sin. 2010 Dec;31(12):1643-8. doi: 10.1038/aps.2010.124. Epub 2010 Nov 22. Acta Pharmacol Sin. 2010. PMID: 21102481 Free PMC article.

7

Prognostic value of lymphadenectomy in node-negative intrahepatic cholangiocarcinoma: A multicenter, retrospectively study.

Chen C, Su J, Wu H, Qiu Y, Song T, Mao X, He Y, Cheng Z, Zhai W, Li J, Geng Z, Tang Z. Chen C, et al. Eur J Surg Oncol. 2023 Apr;49(4):780-787. doi: 10.1016/j.ejso.2022.11.008. Epub 2022 Nov 8. Eur J Surg Oncol. 2023. PMID: 36404249 Free article.

8

A Bayesian Network Prediction Model for Microvascular Invasion in Patients with Intrahepatic Cholangiocarcinoma: A Multi-institutional Study.

Li Q, Zhang J, Cai Z, Chen C, Wu H, Qiu Y, Song T, Mao X, He Y, Cheng Z, Zhai W, Li J, Si S, Zhang D, Geng Z, Tang Z. Li Q, et al. World J Surg. 2023 Mar;47(3):773-784. doi: 10.1007/s00268-022-06867-5. Epub 2023 Jan 6. World J Surg. 2023. PMID: 36607391

9

The optimal number of examined lymph nodes for accurate staging of intrahepatic cholangiocarcinoma: A multi-institutional analysis using the nodal staging score model.

Zhang R, Zhang J, Chen C, Qiu Y, Wu H, Song T, He Y, Li J, Zhang D, Geng Z, Tang Z. Zhang R, et al. Eur J Surg Oncol. 2023 Aug;49(8):1429-1435. doi: 10.1016/j.ejso.2023.03.221. Epub 2023 Mar 23. Eur J Surg Oncol. 2023. PMID: 37005204

10

Preoperative portal vein embolization for hilar cholangiocarcinoma--a comparative study.

Yi B, Xu AM, Lai EC, Qu ZQ, Cheng QB, Liu C, Luo XJ, Yu Y, Qiu YH, Wang XY, Cheng HY, Zhang BH, Shen F, Lau WY, Wu MC, Jiang XQ. Yi B, et al. Among authors: qiu yh. Hepatogastroenterology. 2010 Nov-Dec;57(104):1341-6. Hepatogastroenterology. 2010. PMID: 21443082

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

262 results

Search Page

Filters